DS-8201a in Patients With Cancer That Tests Positive for Human Epidermal Growth Factor Receptor 2 (HER2) Protein
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Adenocarcinoma, Gastric|Neoplasm, Breast
Interventions: DRUG: DS-8201a
Sponsor: Daiichi Sankyo Taiwan Ltd., a Daiichi Sankyo Company
Collaborators: AstraZeneca